Table 3 Comparison of clinical outcomes with different treatments
Variable | Control group(n = 10) | HBOT group(n = 10) | P value |
|---|---|---|---|
Week 4 | |||
CDAI, mean ± SD | 197.67 ± 63.71 | 188.87 ± 51.21 | 0.738 |
CRP, mean ± SD, mg/L | 30.19 ± 16.00 | 25.86 ± 22.40 | 0.875 |
CRP normalization, n (%) | 2 (20%) | 5 (50%) | 0.160 |
FC, n (%) | 0.129 | ||
>1800ug/g | 5 (40%) | 1 (10%) | |
200ug/g- 1800ug/g | 3 (40%) | 4 (40%) | |
≤200ug/g | 2 (20%) | 5 (50%) | |
Clinical response, n (%) | 3 (30%) | 7(70%) | 0.089 |
Clinical remission, n (%) | 2(20%) | 5(50%) | 0.160 |
Week8 | |||
CDAI, mean ± SD | 160.52 ± 75.99 | 146.05 ± 64.34 | 0.651 |
CRP, mean ± SD, mg/L | 16.08 ± 17.91 | 15.9 ± 17.52 | 0.988 |
CRP normalization, n (%) | 7(70%) | 7(70%) | 1.000 |
FC, n (%) | 0.476 | ||
>1800ug/g | 1 (10%) | 0 (0%) | |
200ug/g- 1800ug/g | 3(30%) | 2(20%) | |
≤200ug/g | 6(60%) | 8 (80%) | |
SES-CD, mean ± SD | 8.6 ± 5.9 | 7.2 ± 4.8 | 0.568 |
Clinical response, n (%) | 6(60%) | 8(80%) | 0.628 |
Clinical remission, n (%) | 5 (50%) | 7 (70%) | 0.325 |
Endoscopic response, n (%) | 3 (30%) | 3 (30%) | 1.000 |
Endoscopic remission, n (%) | 1 (10%) | 2(20%) | 0.500 |